 |
Oxandrolone |
|---|---|
| Trade Name | Oxandrin |
| Orphan Indication | Adjunctive therapy for AIDS patients suffering from HIV-wasting syndrome |
| USA Market Approval | USA |
| USA Designation Date | 1991-09-06 00:00:00 |
| Sponsor | Bio-Technology General Corp.;70 Wood Avenue South;Iselin, New Jersey, 08830 |
